Upcoming Conferences

Check out our upcoming conference schedule for CME seminars.

View Upcoming Conferences

Our Culture

The only ACCME-accredited provider focused on cultural diversity.

Learn More

EXCEL Continuing Education

Dedicated to providing effective medical education that addresses the multi-cultural diversity of our country.

Contact us

Scroll Down For More Information About:

EXCEL Continuing Education

Dedicated to providing effective medical education that addresses the multi-cultural diversity of our country.

Our activities provide clinicians with a better understanding of the different health-related cultural beliefs and expectations patients bring with them to a doctor’s office, and how different diseases affect diverse populations. Working with key thought leaders in a variety of therapeutic areas enables us to develop dynamic, innovative medical education activities designed to improve patient care and quality of life. Learners can EXCEL by applying this knowledge in their daily practice and thus, meet the needs of their specific patient population.



EXCEL Continuing Education has been reviewed by the Accreditation Council for Continuing Medical Education (ACCME®) and awarded Accreditation with Commendation for 6 years as a provider of continuing medical education (CME) for physicians. Accreditation in the ACCME System seeks to assure the medical community and the public that EXCEL delivers education that is relevant to clinicians’ needs, evidence-based, evaluated for its effectiveness, and independent of commercial influence.

Activities accredited by ACCME providers are accepted and recognized for credit by the AAPA (physician assistants) and the AANP (nurse practitioners). EXCEL Continuing Education is also accredited by the Florida Board of Nursing and the Florida Board of Pharmacy, allowing our activities to offer continuing education credit to the broadest range of identified target audiences.

Our Culture

EXCEL focuses on the multi-cultural diversity of our country by offering educational activities in different languages, as well as centered on topics that are relevant to these patient populations.


Upcoming Conferences.

Check out our conference schedule to find our latest medical CME conferences.

View Conference Schedule

Online CE Programs


online cme ER Doc as Master Diagnostician: The Patient with Recurrent Encephalopathy

Genetic metabolic diseases, rare disorders with a wide variety of clinical phenotypes, are commonly associated with significant morbidity and mortality. Patients with acute and acute-on-chronic presentations show up in pediatric and adult emergency departments, often in life-threatening circumstances. In some pediatric cases, the diagnoses are already known because the patients have been identified through the newborn screening process or by a specialist. However, most metabolic diseases are not included in the newborn screening panel, and the diagnosis is usually missed or unknown in late-onset cases. This symposium provides emergency medicine clinicians with a practical approach to identify recognizable pediatric and adult metabolic conditions, as well as guidelines for administering first-line treatment that can be lifesaving. In addition to a didactic ppt presentation, this half hour on-demand webinar will also incorporate a sample case presentation of a patient’s experience with a “metabolic crisis”..

Click Here to Participate


online cme Alpha-1 Antitrypsin Deficiency for Nurse Practitioners

Alpha-1 Antitrypsin Deficiency (Alpha-1) is a common genetic disease that is underrecognized, underdiagnosed and often misdiagnosed as COPD or asthma. It can cause liver and lung disease. The liver makes a protein called alpha-1 antitrypsin that goes into the bloodstream. This protein protects the lungs and allows them to work normally. If there is not enough alpha-1 antitrypsin, it is called alpha-1 antitrypsin deficiency. Although Alpha-1 is one of the most common genetic life-threatening diseases worldwide, with an incidence comparable to that of cystic fibrosis, it remains underrecognized and undertreated and therefore continues to pose a significant health threat. According to the Alpha-1 Foundation, it is estimated that 1 in every 2,500 Americans have Alpha-1 yet less than 10% have been diagnosed. This exemplifies a significant healthcare knowledge gap. Many nurses have suboptimal knowledge/awareness of this genetic disorder and easily misdiagnose it for asthma or COPD, leading to an increased risk of patient mortality. This on-demand accredited activity intends to close knowledge gaps by increasing awareness regarding Alpha-1, which is paramount to increasing the number of identified carriers, provide strategies for diagnosing and treating these patients, therefore preventing further damage to improve patient outcomes and prolong their life span.

Click Here to Participate


online cmeComprehensive Genomic Profiling: Towards Precision Medicine

Our understanding of cancer genomics is dramatically changing cancer diagnostics, leading the way to personalized cancer care. Delivering comprehensive genomic profiling for clinical cancer care is transforming cancer care. Therapy targeting the alterations that drive an individual patient’s cancer can yield dramatic results. When correctly implemented, next generation sequencing (NGS) methods provide millions of individual observations that are representative of the genetic makeup of a sample. Hybridization capture of target genomic regions allows NGS to be used for comprehensive profiling of clinical oncology specimens. This enduring activity intends to close knowledge and competence gaps regarding the use of comprehensive genomic profiling, allowing physicians to prescribe the most effective, targeted cancer treatments to patients based on the genomic information specific to their own cancer (precision medicine).

Click Here to Participate


online cme Let’s Talk Period! Is it von Willebrand Disease (vWD)?

Von Willebrand disease, the most common inherited bleeding disorder worldwide and a cause of heavy menstrual bleeding in adolescent girls and women, is widely underrecognized. The underdetection of vWD is a missed opportunity to decrease the risk of obstetric/gynecologic symptoms such as spontaneous abortion, ovarian cysts, postpartum hemorrhage, and a diminished QoL. This educational activity intends to enhance HCP knowledge through discussion of proper diagnosis of this congenital bleeding disorder, and competence in applying best management practices in the multidisciplinary approach to treatment, through discussion of recent therapeutic developments, prophylaxis efficacy and current use, and addressing strategies for care, with the ultimate goal of improving patient quality of life.

Click Here to Participate


online cme The Role of the Genetic Counselor in Pompe Disease

An important part of coordinated care for Pompe disease patients, whether diagnosed thru NBS, clinical diagnosis, or prenatal diagnosis, is genetic counseling. Genetic counselors help families better understand Pompe disease, what to expect at different ages including symptoms, medical recommendations, and treatment options, while providing available resources so families with the affected child, and adults diagnosed with Pompe disease, can make informed decisions. This activity intends to close this knowledge/practice gap by helping guide genetic counselor efforts by providing a clear understanding of the role for families or carriers of Pompe disease identified thru NBS; explain special considerations (i.e., diagnosis of LOPD, before appearance of symptoms) and impact and implications associated with genetic risk, carrier status, and preconception counseling, ending with a framework for a standardized approach to genetic counseling for patients and at-risk family members.

Supported through an educational grant from SANOFI GENZYME.

Click Here to Participate (For Genetic Counselors Only)


online cme Fabry Disease: The Role of the Genetic Counselor in an Ever-Changing Landscape

Fabry disease is the second most common lysosomal storage disorder, affects the cells of multiple organ systems. With a high variability in disease manifestations, the disease can differ from one individual to another, making diagnosis and management a challenge. Growing evidence suggests that initiating certain treatments early in the disease process—before organ damage has ensued—may benefit clinical outcomes and reduce serious complications. Genetic counselors play an important role in providing supportive care strategies by educating patients on Fabry disease, the role of genetic testing, and how the disease can impact patient life and family members. This activity will review these issues including sample patient case scenarios.

Supported through an educational grant from SANOFI GENZYME.

Click Here to Participate (For Genetic Counselors Only)